Towards Healthcare Research & Consulting
Antipsychotic Drugs Market
Updated Date: 21 April 2026   |   Report Code: 5147
[email protected] +1 804-441-9344
Download Sample Order Now

Antipsychotic Drugs Market Size, Advancements Shaping the Mental Health

According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophrenia and bipolar disorder. They work by balancing brain chemicals to reduce hallucinations, delusions, and mood swings. These medications can improve thinking, emotions, and behavior but may have side effects.

Last Updated : 21 April 2026 Category: Therapeutic Area Insight Code: 5147 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Antipsychotic Drugs Market Assessment

  • Overview
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Antipsychotic Drugs Market Assessment

  • Overview
  • North America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • North America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • North America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Europe Antipsychotic Drugs Market Assessment

  • Overview
  • Europe Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Europe Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Europe Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Asia Pacific Antipsychotic Drugs Market Assessment

  • Overview
  • Asia Pacific Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Asia Pacific Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Asia Pacific Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Middle East and Africa Antipsychotic Drugs Market Assessment

  • Overview
  • Middle East and Africa Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Middle East and Africa Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Middle East and Africa Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

South America Antipsychotic Drugs Market Assessment

  • Overview
  • South America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • South America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • South America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Company Profiles

  • Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Dr. Reddy's Laboratories Limited
  • AstraZeneca PLC.
  • Johnson & Johnson (Janssen Pharmaceuticals)
  • Pfizer Inc.
  • Alkermes Plc.
  • AbbVie Inc. (Allergan Inc.)
  • Bristol-Myers Squibb

Conclusion & Recommendations

FAQ's

Answer : Rising prevalence of mental illnesses like schizophrenia and bipolar disorder, Growing geriatric population with increased risk of dementia and Increasing government initiatives for mental healthcare awareness and access to medication.

Answer : Asia Pacific, due to growing awareness, rising disposable income, and development of local pharmaceutical industries.

Answer : Generic alternatives will become available, making treatment more affordable and potentially expanding market reach.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar